Show Entire Article
Take a look at some of Tuesday's midday movers:
Boeing moved higher after it raised the price of its commercial aircraft by 5.5 percent.
Eli Lilly moved lower on lowered expectations for its experimental drug. This comes after the failure of a similar drug co-developed by Johnson & Johnson and Pfizer . Separately, Pfizer agreed to pay $26.3 million to the SEC to settle a foreign bribery case .
West Coast refiners Valero, Tesoro and AlonUSA Energy all rallied at the expense of Chevron as the energy company deals with its Richmond, California refinery fire .
Nu Skin Enterprises got slammed after short-selling website Cintron Research said its China sales are in jeopardy due to violations. Herbalife also fell in sympathy.
Applied Materials rose after Goldman Sachs upgraded the chipmaker to "buy," citing new management. It also upgraded Freescale and LSI to "buy." Altera and NXP Semi remain Goldman's other top picks as it upgrades the semiconductor industry to "attractive" from "neutral."
Tumi rose after its earnings beat Street expectations. The luxury luggage maker also raised its full-year outlook.
Page 1 of 2 | Next PageShow Entire Article
BA News & Analysis
DATA IS REAL-TIME EXCEPT NOTED WITH *
* DATA DELAYED AT LEAST 15 MINUTES